BANK OF AMERICA CORP /DE/
BankPosition in TVTX — Travere Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$259,527,450
+$219,564,205 QoQ
Shares Held
4,568,341
+239.6% QoQ
Ownership
4.85%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4
of 315 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Jun 30, 2025CallValue
$1,184,000
CallShares
80,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. TVTX ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
This page
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TVTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,527,450 | 4,568,341 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $308,998,395 | 5,439,155 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $39,963,245 | 1,345,111 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $70,702,062 | 1,850,355 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $1,184,000 | 80,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $23,996,615 | 1,621,393 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,150,400 | 120,000 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $16,950,633 | 945,906 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,090,400 | 120,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $23,192,776 | 1,331,388 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,678,800 | 120,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $23,987,531 | 1,714,620 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,444,999 | 1,878,954 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,181,268 | 1,709,633 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $14,576,987 | 1,621,467 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,864,117 | 1,215,226 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,728,363 | 1,349,503 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,392,881 | 817,825 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,691,374 | 555,938 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $10,679,415 | 433,418 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,703,712 | 524,297 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,433,057 | 598,877 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,872,922 | 511,370 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $23,169,175 | 955,430 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,401,554 | 1,672,485 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $60,828,691 | 2,436,071 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $65,374,739 | 2,398,633 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||